Characteristics of Turkish colorectal cancer patients and bevacizumab preference.
dc.contributor.author | Cicin, Irfan | |
dc.contributor.author | Gumus, Mahmut | |
dc.contributor.author | Uncu, Dogan | |
dc.contributor.author | Ozkan, Metin | |
dc.contributor.author | Kilickap, Saadettin | |
dc.contributor.author | Elkiran, Tamer E. | |
dc.contributor.author | Isikdogan, Abdurrahman | |
dc.date.accessioned | 2024-04-24T17:15:00Z | |
dc.date.available | 2024-04-24T17:15:00Z | |
dc.date.issued | 2017 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description | 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET -- JUN 02-07, 2017 -- Chicago, IL | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.description.sponsorship | Amer Soc Clin Oncol | en_US |
dc.identifier.doi | 10.1200/JCO.2017.35.15_suppl.e15055 | |
dc.identifier.issn | 0732-183X | |
dc.identifier.issn | 1527-7755 | |
dc.identifier.uri | https://doi.org/10.1200/JCO.2017.35.15_suppl.e15055 | |
dc.identifier.uri | https://hdl.handle.net/11468/18300 | |
dc.identifier.volume | 35 | en_US |
dc.identifier.wos | WOS:000411895707157 | |
dc.identifier.wosquality | Q1 | |
dc.indekslendigikaynak | Web of Science | |
dc.language.iso | en | en_US |
dc.publisher | Amer Soc Clinical Oncology | en_US |
dc.relation.ispartof | Journal of Clinical Oncology | |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [No Keyword] | en_US |
dc.title | Characteristics of Turkish colorectal cancer patients and bevacizumab preference. | en_US |
dc.title | Characteristics of Turkish colorectal cancer patients and bevacizumab preference. | |
dc.type | Conference Object | en_US |